University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
-
Doctors test direct tumor injection for tough lung cancers
Disease control OngoingThis early-stage study is testing a new way to deliver chemotherapy directly into lung tumors. Doctors use a special ultrasound-guided needle to inject the drug cisplatin right into the cancer. The goal is to find the safest and most effective dose for patients with stage IV lung…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for older AML patients: gentler treatment combo under the microscope
Disease control ENROLLING_BY_INVITATIONThis study is testing whether adding a common anti-inflammatory drug, dexamethasone, to a standard low-intensity leukemia treatment is safe and tolerable. It is for adults newly diagnosed with Acute Myeloid Leukemia (AML) who cannot receive strong chemotherapy. The main goal is t…
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New clinic program aims to stop deadly clots in cancer patients
Prevention ENROLLING_BY_INVITATIONThis study is testing a new clinic program designed to help prevent dangerous blood clots in cancer patients who are starting treatment. It will see if training doctors and using a specific process leads to more patients being checked for clot risk and getting the right preventiv…
Phase: NA • Sponsor: University of Vermont • Aim: Prevention
Last updated Mar 23, 2026 15:18 UTC